B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site
- B.Braun Medical, Inc.
BETHLEHEM, Pa., Jan. 28, 2022 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona Beach, FL. The site will produce 0.9% Sodium Chloride for Injection available in B. Braun’s Excel® Plus IV Bags in 1,000 mL and 500 mL sizes. Consistent with B. Braun’s decades-long commitment to protect patients from exposure to harmful chemicals, the Excel Plus IV bags are not made with PVC, DEHP or natural rubber latex. Read more…
Related Reading
Resource / Digital Health / Global & Trade / Regulatory Affairs
EY Pulse of the MedTech Industry Report 2026
November 5, 2026
The 20th edition of the EY Pulse of the MedTech Industry Report captures the medical devices sector at both a high point and a turning point.
Resource / Government & Legislative Affairs / Regulatory Affairs
Justin Klein Op-Ed: CMS Can Make RAPID a Win for Patients and American Medtech Innovation
November 5, 2026
In this op-ed published in Medtech Insight, Justin Klein, MD, JD, explains how the proposed RAPID coverage pathway could accelerate Medicare access to breakthrough medical technologies and why targeted refinements are essential to its success.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Tariffs
AdvaMed® Advancements: Q3 2026 Report
November 5, 2026
Explore AdvaMed’s Q3 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation, expanding patient access to medtech, and strengthening the industry to serve patients.
News / Digital Health / Health Access / Regulatory Affairs
AdvaMed Digital Health Tech Board Approves Best Practices to Advance Responsible Data Access and Patient Care
October 28, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today announced that its Digital Health Tech Board of Directors has approved voluntary Data Access Principles & Best Practices to help medical technology companies and health systems collaborate on responsible data access, use, and protection. The framework puts patient trust at the center of efforts to improve care, support research, and advance innovation, including artificial intelligence.
Event / Regulatory Affairs
When MedTech Meets Connectivity: The Hidden Risk from Standard-Essential Patents (SEPs) — and How to Navigate It
November 11, 2026
1:00 PM
Join McDermott Will & Schulte Law in this session that will explore explore practical guidance for companies developing connected medical technologies navigating SEPs, FRAND licensing and patent pools.
News / AdvaMed Advancements / Artificial Intelligence (AI) / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Global & Trade / Health Access / Investor Relations / Medical Imaging / Orthopedic / Regulatory Affairs / Tariffs / The MedTech Conference / Value-Based Collaborations
AdvaMed Concludes Record-Breaking MedTech Conference 2026
October 28, 2026
BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.
News / Artificial Intelligence (AI) / Regulatory Affairs
AdvaMed Encourages Risk-Based FDA Approach to Generative AI Medical Devices
October 27, 2026
WASHINGTON—AdvaMed, the Medtech Association, encouraged the U.S. Food and Drug Administration (FDA) to build on its existing regulatory framework for generative AI (GenAI)-enabled medical devices rather than create new frameworks that could impede the innovations serving patients. The comments respond to FDA’s discussion paper (Docket No. FDA-2026-N-7874) seeking early input on assessing risks and evaluating GenAI devices before marketing and post-market monitoring.
News / Health Access / Regulatory Affairs
AdvaMed Spotlights Small Company Innovation Award Winners at The MedTech Conference 2026
October 22, 2026
BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, held October 18-21 in Boston. The conference recognized companies developing technologies to address a diverse array of patient needs through awards offered in several competitions and programs.